X
Get new exclusive access to healthcare business reports & breaking news
Anca Spanu Anca's career in journalism spans over 2 decades. She has served as staff writer, editor and deputy chief editor at various media outlets all over the world. At Healthcare Weekly, Anca writes about current events, innovations in the healthcare space and events/ conferences with a focus on investing & startups.
There is good news for all patients suffering from relapsed/refractory non-Hodgkin lymphoma. A new drug is one step ...
According to Renaissance Capital, the IPO assigns Allogene a fully diluted market value of $2.1 billion and an ...
